PBI4050
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Liminal BioSciences Ltd.
Overview
PBI4050 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
PBI4050 clinical trials
Explore related
Medical disclaimer. This page summarizes research about PBI4050 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.